AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure, chronic kidney disease across India Read more
India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025 Read more
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD: GlobalData Read more